RxDoctor Payments Data

Katie Joshi, PA

Medical · Albuquerque, NMNPI 1417144890

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.3% of the total. 2025 is the largest year on record at $1,446, 2.3 times the $621 reported in 2021. Among medical clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,617in general payments, 2019–2025

Across 211 payments — averaging $26.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$763
  • Sanofi$631
  • Johnson & Johnson$567
  • Incyte Corporation$437
  • Amgen$404
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$5,51798%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,617 in reported general payments places this provider in the 95th percentile of 156 medical providers in New Mexico.

See all medical providers in New Mexico

Medicare billing

Part B allowed, 2024
$72,426
Medicare patients
301
Services billed
1,606

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate62$1,147
Fluorouracil26$978
Metronidazole13$855
Betamethasone Dipropionate20$627
Ciclopirox16$416
Clobetasol Propionate18$413
ValacyclovirValacyclovir Hcl13$407
Minoxidil20$325
Ketoconazole14$301
Mometasone Furoate13$214
Triamcinolone Acetonide16$123

Paid to pharmacies, not to this prescriber.

Other medical in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →